Synthesis and evaluation of antitubercular activity of fluorinated 5-aryl-4-(hetero)aryl substituted pyrimidines. 2016

Egor V Verbitskiy, and Svetlana A Baskakova, and Marionella A Kravchenko, and Sergey N Skornyakov, and Gennady L Rusinov, and Oleg N Chupakhin, and Valery N Charushin
Postovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, S. Kovalevskoy Str., 22, Ekaterinburg 620990, Russia; Ural Federal University, Mira St. 19, Ekaterinburg 620002, Russia. Electronic address: Verbitsky@ios.uran.ru.

Various 5-(fluoroaryl)-4-(hetero)aryl substituted pyrimidines have been synthesized based on the Suzuki cross-coupling and nucleophilic aromatic substitution of hydrogen (SN(H)) reactions starting from commercially available 5-bromopyrimidine and their antitubercular activity against Mycobacterium tuberculosis H37Rv has been explored. The outcome of the study disclose that, some of the compounds have showed promising activity in micromolar concentration against Mycobacterium tuberculosis H37Rv, Mycobacterium avium, Mycobacterium terrae, and multidrug-resistant strains isolated from tuberculosis patients in Ural region (Russia). The data concerning the 'structure-activity' relationship for fluorinated compounds have been discussed.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009161 Mycobacterium A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts. Mycobacteria
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D005461 Fluorine A nonmetallic, diatomic gas that is a trace element and member of the halogen family. It is used in dentistry as fluoride (FLUORIDES) to prevent dental caries. Fluorine-19,Fluorine 19
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass

Related Publications

Egor V Verbitskiy, and Svetlana A Baskakova, and Marionella A Kravchenko, and Sergey N Skornyakov, and Gennady L Rusinov, and Oleg N Chupakhin, and Valery N Charushin
January 2009, Arzneimittel-Forschung,
Egor V Verbitskiy, and Svetlana A Baskakova, and Marionella A Kravchenko, and Sergey N Skornyakov, and Gennady L Rusinov, and Oleg N Chupakhin, and Valery N Charushin
January 1970, Journal of medicinal chemistry,
Egor V Verbitskiy, and Svetlana A Baskakova, and Marionella A Kravchenko, and Sergey N Skornyakov, and Gennady L Rusinov, and Oleg N Chupakhin, and Valery N Charushin
July 2003, Archiv der Pharmazie,
Egor V Verbitskiy, and Svetlana A Baskakova, and Marionella A Kravchenko, and Sergey N Skornyakov, and Gennady L Rusinov, and Oleg N Chupakhin, and Valery N Charushin
January 1991, Die Pharmazie,
Egor V Verbitskiy, and Svetlana A Baskakova, and Marionella A Kravchenko, and Sergey N Skornyakov, and Gennady L Rusinov, and Oleg N Chupakhin, and Valery N Charushin
February 2011, Bioorganic & medicinal chemistry letters,
Egor V Verbitskiy, and Svetlana A Baskakova, and Marionella A Kravchenko, and Sergey N Skornyakov, and Gennady L Rusinov, and Oleg N Chupakhin, and Valery N Charushin
November 1962, Journal of medicinal and pharmaceutical chemistry,
Egor V Verbitskiy, and Svetlana A Baskakova, and Marionella A Kravchenko, and Sergey N Skornyakov, and Gennady L Rusinov, and Oleg N Chupakhin, and Valery N Charushin
September 1963, Journal of medicinal chemistry,
Egor V Verbitskiy, and Svetlana A Baskakova, and Marionella A Kravchenko, and Sergey N Skornyakov, and Gennady L Rusinov, and Oleg N Chupakhin, and Valery N Charushin
October 1966, Ceskoslovenska farmacie,
Egor V Verbitskiy, and Svetlana A Baskakova, and Marionella A Kravchenko, and Sergey N Skornyakov, and Gennady L Rusinov, and Oleg N Chupakhin, and Valery N Charushin
March 1982, Chemical & pharmaceutical bulletin,
Egor V Verbitskiy, and Svetlana A Baskakova, and Marionella A Kravchenko, and Sergey N Skornyakov, and Gennady L Rusinov, and Oleg N Chupakhin, and Valery N Charushin
February 2006, European journal of medicinal chemistry,
Copied contents to your clipboard!